| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 01/04/1995 | CN1027271C Method for preparation of polypeptide with nor-state and nor-cyclostatine |
| 01/04/1995 | CN1027225C Pharmaceutical composition containing calcitonins and process for preparing same |
| 01/04/1995 | CN1027224C Stabilised human protein preparations |
| 01/03/1995 | US5378823 Trophoblastin |
| 01/03/1995 | US5378816 Methods for high purity chromatographic separation of proteins having EGF-like binding domains |
| 01/03/1995 | US5378812 Human antibodies which specifically bind to lipopolysaccharide determinants of some pseudomonas serotypes and inhibit these bacteria, for prevention and treatment of infections |
| 01/03/1995 | US5378811 Pure C3b inactivator and a process for producing said protein |
| 01/03/1995 | US5378809 Polynucleotides and substrate for the epidermal growth factor receptor kinase (eps8) |
| 01/03/1995 | US5378808 Isolated DNA sequence; anemia; genetic engineering |
| 01/03/1995 | US5378804 Fungicides, antiprotozoa agents, microbiocides |
| 01/03/1995 | US5378729 Diamide derivatives |
| 01/03/1995 | US5378696 Immunosuppressants, transplant rejection, autoimmune diseases, antitumor agents, antiinflammatory agents, fungicides |
| 01/03/1995 | US5378692 Method of lowering lipids |
| 01/03/1995 | US5378688 Conjugating luteinizing hormone releasing hormone to plant, bacterialo or chemical toxins |
| 01/03/1995 | US5378687 Use of human blood coagulation factor XIII for the treatment of ulcerative colitis |
| 01/03/1995 | US5378686 Administering human growth hormone |
| 01/03/1995 | US5378614 Vector and method for making tissue factor pathway inhibitor (TFPI) analogues in yeast |
| 01/03/1995 | US5378601 Method of preserving platelets with apyrase and an antioxidant |
| 01/03/1995 | US5378469 Dehydration |
| 01/03/1995 | US5378464 Modulation of inflammatory responses by administration of GMP-140 or antibody to GMP-140 |
| 01/03/1995 | US5378462 And coated with a gastric juice resistant film; treatment of digestive disorders; high bulk density, small paticle size |
| 01/03/1995 | CA2127216A1 Cosmetic composition containing a superoxyde dismutase and a melanin pigment in association |
| 01/02/1995 | CA2127230A1 Methods and reagents for inhibiting cholesterol absorption in humans mediated by pancreatic cholesterol esterase |
| 01/02/1995 | CA2127187A1 Anti-picornaviral agents |
| 12/31/1994 | CA2127068A1 Process for the preparation of native human glicentin |
| 12/29/1994 | CA2126932A1 Semi-solid pharmaceutical composition comprising an anhydrous oligosaccharide and process to produce the same |
| 12/28/1994 | EP0630651A2 Semi-solid pharmaceutical agent and process to produce the same |
| 12/28/1994 | EP0630412A1 Methods to profile and treat abnormal cells |
| 12/28/1994 | EP0630407A1 Anti-viral fusion peptides |
| 12/28/1994 | EP0630405A1 Novel V28 seven transmembrane receptor |
| 12/28/1994 | EP0630404A1 Protein compound capable of inhibiting tumoral growth |
| 12/28/1994 | EP0630385A1 Potent peptide for stimulation of cytotoxic t lymphocytes specific for the hiv-1 envelope |
| 12/28/1994 | EP0630384A1 Methods and compounds for prevention of graft rejection |
| 12/28/1994 | EP0630383A1 Methods of treating diabetes |
| 12/28/1994 | EP0630275A1 Fibrin sealant delivery method |
| 12/28/1994 | EP0630260A1 Polysaccharide-protein conjugates |
| 12/28/1994 | EP0630257A1 Immune-enhancing agent for therapeutic use in immunocompromised hosts |
| 12/28/1994 | EP0630256A1 Tissue irrigating solution |
| 12/28/1994 | EP0630255A1 Mhc conjugates useful in ameliorating autoimmunity |
| 12/28/1994 | EP0630250A1 Pharmaceutical compositions containing monosialoganglioside gm 1? or a derivative thereof suitable for the treatment of parkinson's disease |
| 12/28/1994 | EP0630238A1 Reducing post-prandial fluctuations in plasma concentrations of large neutral amino acids (lnaa) |
| 12/28/1994 | EP0630234A1 Controlled release acth containing microspheres. |
| 12/28/1994 | EP0630181A1 Nutritional product for trauma and surgery patients |
| 12/28/1994 | EP0617705A4 Non-peptidic surrogates of the arg-gly-asp sequence and pharmaceutical compositions comprising them. |
| 12/28/1994 | EP0413818B1 Process for producing a human neutrophil chemotactic factor polypeptide |
| 12/28/1994 | EP0346429B1 Peptide analogues of insulin-like growth factor 1 (igf-1) or factor 2 (igf-2) |
| 12/28/1994 | EP0248887B1 Cell-free t cell antigen receptor and its clinical utilities |
| 12/28/1994 | CN1096821A BPI-immunoglobulin fusion proteins |
| 12/28/1994 | CN1027136C Wound healing |
| 12/27/1994 | US5376640 Administering purithionin or polylysine |
| 12/27/1994 | US5376639 Treatment of sarcoma with interleukin 1α polypeptides |
| 12/27/1994 | US5376638 Methods for treating renin-related disorders with amylin antagonists |
| 12/27/1994 | US5376637 Pharmaceutical preparation containing vasoactive intestinal polypeptide or its analogue |
| 12/27/1994 | US5376636 Method for promoting tissue repair and regeneration using PDGF and glucocorticoids |
| 12/27/1994 | US5376635 Fluorine containing atrial natriuretic peptides |
| 12/27/1994 | US5376634 Microbiocides |
| 12/27/1994 | US5376633 Using alpha 1-antitrypsin |
| 12/27/1994 | US5376632 Cyclodextrin based erythropoietin formulation |
| 12/27/1994 | US5376631 Oxidation products containing the D-region of fibrinogen with methionine residues which have been oxidized to methionine sulfoxide, as stimulants for plasminogen activators |
| 12/27/1994 | US5376567 Expression of interferon genes in Chinese hamster ovary cells |
| 12/27/1994 | US5376547 With modifications in amino acid content which eliminate binding to liver membranes and aid in maintaining concentration in blood |
| 12/27/1994 | US5376546 Analogs of ribosome-inactivating proteins |
| 12/27/1994 | US5376373 Method of inhibiting radiation induced weight and hair loss |
| 12/27/1994 | US5376368 Composition and method for treating inflammation |
| 12/27/1994 | US5376367 Fusion proteins comprising MGF and IL-3 |
| 12/25/1994 | CA2126619A1 Sustained-release preparation of anti-endothelin substance |
| 12/22/1994 | WO1994029727A1 Inhibiting protein interactions |
| 12/22/1994 | WO1994029720A1 Leukocyte adhesion assay |
| 12/22/1994 | WO1994029522A1 Paper strengthened with solubilized collagen, and method for making the same |
| 12/22/1994 | WO1994029487A1 Compositions and methods for inhibiting replication of human immunodeficiency virus-1 |
| 12/22/1994 | WO1994029470A1 Retroviral vectors for transducing beta-globin gene and beta-locus control region derivatives |
| 12/22/1994 | WO1994029469A2 Plasmids suitable for gene therapy |
| 12/22/1994 | WO1994029462A1 Multicistronic expression of recombinant genes in bacterial cells |
| 12/22/1994 | WO1994029461A1 Method for specific silencing of genes by dna methylation |
| 12/22/1994 | WO1994029458A1 Hybrid receptor molecules |
| 12/22/1994 | WO1994029455A1 Mutant polypeptide of protein kinase c, nucleic acid sequences coding for said polypeptide and use thereof |
| 12/22/1994 | WO1994029451A2 Humanised antibodies |
| 12/22/1994 | WO1994029448A1 Dna and protein coded for thereby |
| 12/22/1994 | WO1994029446A2 Intracellular binding proteins and use thereof |
| 12/22/1994 | WO1994029441A1 Protein which catalyses peptide refolding and uses thereof |
| 12/22/1994 | WO1994029440A1 Generation, concentration and efficient transfer of vsv-g pseudotyped retroviral vectors |
| 12/22/1994 | WO1994029436A1 Methods for selectively stimulating proliferation of t cells |
| 12/22/1994 | WO1994029370A1 Factor ix - polymeric conjugates |
| 12/22/1994 | WO1994029351A3 Antibodies |
| 12/22/1994 | WO1994029351A2 Antibodies |
| 12/22/1994 | WO1994029350A2 Recombinant disulfide-stabilized polypeptide fragments having binding specificity |
| 12/22/1994 | WO1994029349A1 Trifunctional antithrombin and antiplatelet peptides |
| 12/22/1994 | WO1994029348A2 Production of antibody fragments |
| 12/22/1994 | WO1994029347A1 Antibody fragments in therapy |
| 12/22/1994 | WO1994029346A1 IDENTIFICATION OF THE ADHESIN GENE FROM $i(M. PIRUM) |
| 12/22/1994 | WO1994029344A1 Super proteins including interferons and interleukins |
| 12/22/1994 | WO1994029342A1 Cell surface lamp expression and selectin-dependent adhesion |
| 12/22/1994 | WO1994029341A1 Methods of enhancing bioactivity of chemokines |
| 12/22/1994 | WO1994029340A1 Human-origin tumor cell proliferation inhibiting factor |
| 12/22/1994 | WO1994029337A1 Anti-inflammatory composition and method with des-tyr dynorphin and analogues |
| 12/22/1994 | WO1994029336A1 New peptide derivatives |
| 12/22/1994 | WO1994029335A1 New peptides derivatives |
| 12/22/1994 | WO1994029334A1 Immunoglobulin g concentrate for therapeutical use and method for producing same |
| 12/22/1994 | WO1994029333A1 Immunoreactive reagents employing monoamine oxidase |
| 12/22/1994 | WO1994029332A1 Coiled-coil stem loop templates |